Clinical Trials Directory

Trials / Conditions / Durvalumab

Durvalumab

11 registered clinical trials studyying Durvalumab — 4 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationEvaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain
NCT07088081
Ain Shams University—
RecruitingPhoton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
NCT06999707
Chang Gung Memorial HospitalPhase 2
RecruitingProton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
NCT06999694
Chang Gung Memorial HospitalPhase 2
RecruitingHepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally
NCT06859684
West China HospitalPhase 2
UnknownDurvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Re
NCT05672537
Tianjin Medical University Cancer Institute and HospitalPhase 2
UnknownLow-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
NCT05092412
You LuPhase 2
WithdrawnTrial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasiv
NCT05120622
University of British ColumbiaPhase 1 / Phase 2
UnknownAn Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese
NCT05245994
Li Zhang, MDPhase 2
UnknownProspective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize
NCT05027165
LMU Klinikum—
UnknownEfficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
NCT04356222
Hui BuPhase 4
UnknownAnlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemot
NCT04314297
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2